Publications by authors named "Angela Capriati"

Claim this Profile
P
Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK receptors, in infants with colic.
Siv Jönsson, Salim Bouchene, Paolo Mazzei, Elisa Borella, Chiara Piana, Angela Capriati

Br J Clin Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram-negative bacterial infections.
Chiara Fornari, Antonio Arrieta, John S Bradley, Mira Tout, Paulo Magalhaes, Angela Capriati

Br J Clin Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
Paul Sabbatini, Philipp Harter, Giovanni Scambia, Jalid Sehouli, Werner Meier, Angela Capriati

J Clin Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacologic study of the novel prodrug delimotecan (MEN 4901/T-0128) in patients with solid tumors.
Stephan A Veltkamp, Els O Witteveen, Angela Capriati, Attilio Crea, Fabio Animati

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Alessandro Lecci, Angela Capriati, Maria Altamura, Carlo Alberto Maggi

Auton Neurosci· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
Stefano Ghio, Giulia Magrini, Alessandra Serio, Catherine Klersy, Alessandro Fucili, Angela Capriati

Eur Heart J· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer.
Francesco Caponigro, Pax Willemse, Roberto Sorio, Anne Floquet, Simon van Belle, Angela Capriati

Invest New Drugs· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
Alessandro Lecci, Angela Capriati, Carlo Alberto Maggi

Br J Pharmacol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis